The new The Kennedy C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center.
Memorial Sloan Kettering Cancer Center (MSK) and United Healthcare (UHC) announced a new, multi-year agreement that ensures continued in-network access to MSK for UHC’s commercial members. As a result, current and new UHC-insured patients can continue to receive care at MSK without interruption.
The new agreement, effective today, includes market-aligned rate adjustments consistent with those of other National Cancer Institute (NCI)-designated cancer centers in Manhattan. These adjustments will support MSK’s continued delivery of superior patient outcomes and exceptional cancer care.
“We have reached an agreement with UnitedHealthcare that protects access to MSK for thousands of patients and ensures we can continue delivering the highest standard of cancer care,” said Selwyn M. Vickers, MD, FACS, President & CEO of MSK. “This agreement recognizes the value of MSK’s specialized cancer care model and allows us to continue advancing our mission to end cancer for life.”
###
About Memorial Sloan Kettering Cancer Center
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years. www.mskcc.org
